Hampl SE, Hassink SG, Skinner AC, Armstrong SC, Barlow SE, Bolling CF, Avila Edwards KC, Eneli I, Hamre R, Joseph MM, Lunsford D, Mendonca E, Michalsky MP, Mirza N, Ochoa ER, Sharifi M, Staiano AE, Weedn AE, Flinn SK, Lindros J, Okechukwu K
Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes
If a patient discontinued medication in a bin, they would not be included in the next bin
If a person needs a higher dose to manage their blood sugar, there is also a 9 mg dose
Healthcare professionals must consider whether weight loss will meaningfully improve health outcomes and quality of life in older patients, taking into account their overall clinical picture and life expectancy
For beginners, that is useful because they are often not just choosing a single product